BioWorld - Sunday, April 19, 2026

tau

48 items

budget

48 items

induced pluripotent stem cells

48 items

remote patient monitoring

48 items

cd19

47 items

university of oxford

47 items

drug developers index

47 items

tirzepatide

47 items

paxlovid

47 items

dry eye disease

47 items

boehringer ingelheim pharma gmbh & co. kg

47 items

hoffmann-la roche inc.

47 items

ozempic

46 items

radiotherapy

46 items

myasthenia gravis

46 items

pdufa

46 items

skin cancer

46 items

adeno-associated viruses

46 items

blood-brain barrier

46 items

fraud

46 items